Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Ranbaxy Southeast Asia Area Director Jeyabalan Thangarajah Says Lipitor Generic Sales In Malaysia Strong: An Interview With PharmAsia News

This article was originally published in PharmAsia News

Executive Summary

Ranbaxy Malaysia Managing Director Jeyabalan Thangarajah, who is also the Area Director for the Association of South East Asian region, sees Asia continuing to be a major catalyst for growth in the global pharmaceutical market, which he says is poised to grow to $1 trillion by 2014. Thangarajah sat down with PharmAsia News' Singapore bureau to discuss his views on the Southeast Asian pharma market and trends in the region, including Ranbaxy's experience in selling generic versions of Pfizer Inc's Lipitor in Malaysia, as well as assimilating with parent company Daiichi Sankyo Co. Ltd.

Table

View full table

Tags:
Latest Headlines

BridgeBio Spins Out Cancer Arm With $200m Fundraise

Emergex Goes To Battle Against ‘The Nasties’

Finance Watch: Venture Rounds Trend Toward The High End

The UK’s Cancer Vaccine Partnership With BioNTech Is Another First – But Can It Deliver?

See All
UsernamePublicRestriction

Register

SC076569

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By